4//SEC Filing
Molecular Insight Pharmaceuticals, Inc. 4
Accession 0001209191-07-007509
CIK 0001340752operating
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 4:06 PM ET
Size
12.0 KB
Accession
0001209191-07-007509
Insider Transaction Report
Form 4
Kronauge James F
VP Process Chemistry
Transactions
- Conversion
Series A Convertible Preferred Stock
2007-02-01−152→ 0 total→ Common Stock (6,569 underlying) - Conversion
Common Stock
2007-02-01$6569.00/sh+6,569$43,151,761→ 6,569 total
Footnotes (4)
- [F1]The reporting person held 152 shares of Series A Convertible Preferred Stock. In connection with the issuer's IPO, the Series A Convertible Preferred Stock automatically converted into 6569 shares of Common Stock, which number of shares includes accrued and unpaid dividends on the Series A Preferred Stock as of February 1, 2007.
- [F2]Immediately.
- [F3]Not applicable.
- [F4]The reporting person holds Employee Stock Options to purchase 21,832 shares of Common Stock, as previously reported on Form 3.
Issuer
Molecular Insight Pharmaceuticals, Inc.
CIK 0001340752
Entity typeoperating
IncorporatedMA
Related Parties
1- filerCIK 0001340752
Filing Metadata
- Form type
- 4
- Filed
- Feb 4, 7:00 PM ET
- Accepted
- Feb 5, 4:06 PM ET
- Size
- 12.0 KB